MacroGenics Inc — Cash Flow (NASDAQ:MGNX) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -111.9 M-143.83 M-86.96 M-78.2 M-68.37 M-81.04 M -81.04 M Cash from investing activities -7.79 M-36.61 M70.72 M-80.08 M149.3 M-114.1 M -114.1 M Cash from financing activities 174.34 M122.78 M1.66 M150.36 M960 K69.51 M 69.51 M Free cash flow -117.8 M-150.03 M-90.58 M-79.97 M-72.08 M-82.95 M -82.95 M

News

MacroGenics: Oncology Opportunities In Play, But Investing Feels Like A Gamble (MGNX)

MacroGenics at The Citizens Life Sciences Conference: Strategic Reemergence in 2026

MacroGenics at Leerink Global Healthcare Conference: Strategic Pipeline Focus

Stifel reiterates MacroGenics stock rating with $4 price target

MacroGenics Inc earnings missed by $0.03, revenue topped estimates

MacroGenics (MGNX) Reports Q4 Loss, Tops Revenue Estimates

Stifel reiterates Incyte stock rating after FDA setback

MacroGenics at TD Cowen Conference: Strategic Imperatives in Focus

BioLife Solutions, Inc. (BLFS) Surpasses Q4 Earnings and Revenue Estimates

MacroGenics stock falls after FDA places partial clinical hold

Why Is MacroGenics Stock Sinking Tuesday? - Macrogenics (NASDAQ:MGNX)

Sanofi's Teizeild Gets EU Approval for Treating Type 1 Diabetes